Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Lung Diseases(Electronic Edition) ›› 2025, Vol. 18 ›› Issue (03): 463-466. doi: 10.3877/cma.j.issn.1674-6902.2025.03.022

• Original articles • Previous Articles    

Pulmonary sarcomatoid carcinoma with pneumothorax as the first manifestation:A case report and literature review

Ziheng Guo1, Hong Wang1, Hanfei Gao1, Zhiqiang Wu1,()   

  1. 1. Department of Thoracardiac Surgery,The First Affiliated Hospital of Chengdu Medical College,Chengdu 610500,China
  • Received:2025-02-24 Online:2025-06-25 Published:2025-07-17
  • Contact: Zhiqiang Wu

Abstract:

Objective

To analyze a case of pulmonary sarcomatoid carcinoma (PSC) presented as spontaneous pneumothorax (SP) in our hospital and review the literature,and enhance clinical awareness to reduce the rates of missed diagnosis and misdiagnosis.

Methods

A retrospective analysis was conducted on the clinical data of a patient with PSC who presented with SP as the initial manifestation at our hospital on August 26,2022,and it was explored that the clinical manifestations,pathological characteristics,diagnostic points and treatment strategies of PSC,and relevant literature was analyzed.

Results

A 74-year-old male presented with SP. Preoperative chest CT showed right pneumothorax and right lung compression of about 30%;Soft tissue nodular shadow in the upper lobe of the right lung,about 2.0 cm×1.8 cm in size,and another thick-walled cavity shadow was seen around the lesion. Right upper lobectomy and systematic lymph node dissection were performed with single port thoracoscopic surgery. Postoperative pathological examination:PSC. TNM stage was pT1bN0M0 IA2. The whole gene detection results based on second-generation sequencing:microsatellite stability (MSS) and tumor mutation burden low (TMB-L). Targeted drug use related mutation results:TP53 splice region mutation,NF1 nonsense mutation,NF1 missense mutation,ATR missense mutation,ALK missense mutation,SDHA missense mutation,KMT2C missense mutation. The patient died after 2 months of follow-up with progressive disease.

Conclusion

PSC progresses rapidly and has a poor prognosis. PSC with SP as the first manifestation is extremely rare. The combination of SP may be one of the risk factors for poor prognosis of PSC.

Key words: Pulmonary sarcomatoid carcinoma, Spontaneous pneumothorax, Second-generation sequencing, Full genetic testing

京ICP 备07035254号-28
Copyright © Chinese Journal of Lung Diseases(Electronic Edition), All Rights Reserved.
Tel: 023-65425691 E-mail: xqcjld@163.com
Powered by Beijing Magtech Co. Ltd